SC TO-I/A
EX-FILING FEES
0001830921
0-11
0-11
false
0001830921
1
2025-09-16
2025-09-16
0001830921
2
2025-09-16
2025-09-16
0001830921
1
2025-09-16
2025-09-16
0001830921
2025-09-16
2025-09-16
iso4217:USD
xbrli:pure
xbrli:shares
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
SC TO
Aspiriant Real Assets Fund
Table 1 to Paragraph (a)(7)
| |
|
|
|
|
|
|
|
|
|
|
| Line Item Type |
|
Notes |
|
Transaction
Valuation |
|
Fee Rate |
|
Amount
of
Filing Fee |
| |
|
|
|
|
|
|
|
|
|
|
| Fees to be Paid |
|
|
|
$ |
0.00 |
|
0.0001531 |
|
$ |
0.00 |
| Fees Previously Paid |
|
(1) |
|
$ |
9,200,000.00 |
|
|
|
$ |
1,408.52 |
| |
|
|
|
|
|
|
| Total Transaction Valuation: |
|
$ |
9,200,000.00 |
|
|
|
|
|
| Total Fees Due for Filing: |
|
|
|
|
|
|
$ |
1,408.52 |
| Total Fees Previously Paid: |
|
|
|
|
|
|
|
1,408.52 |
| Total Fee Offsets: |
|
|
|
|
|
|
|
0.00 |
| Net Fee Due: |
|
|
|
|
|
|
$ |
0.00 |
__________________________________________
Offering Note(s)
| (1) | |
Calculated as the aggregate maximum value of Shares being purchased. The fee of $1,408.52 was paid in connection with the filing of the Schedule TO-I by Aspiriant Real Assets Fund (File No. 005-92444) on April 25, 2025 (the “Schedule TO”). This is the final amendment to the Schedule TO and is being filed to report the results of the offer. |
Table 2 to Paragraph (a)(7)
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line Item Type |
|
Notes |
|
Registrant or Filer Name |
|
Form or Filing Type |
|
File Number |
|
Initial Filing Date |
|
Filing Date |
|
Fee Offset Claimed |
|
Fee Paid
with Fee
Offset Source |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fee Offset Sources |
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
|
__________________________________________
Offset Note(s)